DNA Damage Checkpoints and p53 Pathway

When DNA is damaged, the cell does more than repair the lesion: it halts the cell cycle to provide time for repair and, if the damage is severe, can trigger senescence or programmed cell death. DNA damage checkpoints are the surveillance circuits that link lesion detection to these decisions, and the transcription factor p53 is a central hub through which the response to many forms of damage is executed.

Definition

DNA damage checkpoints are signalling pathways that detect DNA lesions or stalled replication and arrest cell-cycle progression to allow repair; the p53 pathway is a downstream branch in which the p53 transcription factor, activated through this signalling, regulates genes governing cell-cycle arrest, senescence, and apoptosis.

Scope

This entry describes how damage is sensed and transduced by the ATM and ATR kinases, how checkpoints arrest the cell cycle, and how the p53 pathway integrates these signals to promote repair, arrest, senescence, or apoptosis. It treats the signalling logic as a mechanistic reference and does not give clinical guidance.

Core questions

• How does a cell sense DNA damage and convert it into a signal?
• How do checkpoints arrest the cell cycle to allow repair?
• What is the role of p53 in the damage response?
• How does the cell decide between arrest, senescence, and death?

Key concepts

• Sensor, transducer, effector logic
• ATM and ATR kinases
• Checkpoint kinases CHK1 and CHK2
• G1/S, intra-S, and G2/M checkpoints
• p53 stabilisation and activation
• Cell-cycle arrest
• Senescence
• Apoptosis

Key theories

The DNA damage response as a sensor-transducer-effector network

DNA damage is handled by a signalling network in which sensors detect lesions, transducer kinases such as ATM and ATR amplify and relay the signal, and effectors including the checkpoint kinases and p53 enact cell-cycle arrest, repair, or death, coordinating the cellular response to genotoxic stress.

Mechanisms

Damage is detected by sensor complexes that activate the apical kinases ATM and ATR; Bakkenist and Kastan showed that ATM is activated by autophosphorylation and dissociation of an inactive dimer in response to double-strand breaks. These kinases phosphorylate a broad set of substrates, mapped at scale by Matsuoka and colleagues, including the checkpoint kinases CHK1 and CHK2, which slow or arrest the cell cycle at the G1/S, intra-S, and G2/M transitions to provide time for repair. A central effector is p53: damage signalling stabilises and activates p53, which Kruse and Gu describe as regulated through post-translational modification and turnover, and which Vousden and Prives describe as orchestrating a transcriptional programme that can drive cell-cycle arrest, senescence, or apoptosis depending on context. The decision among these outcomes integrates the type and extent of damage with cellular state.

Clinical relevance

The gene encoding p53 is among the most frequently altered in human cancer, and loss of checkpoint function contributes to genomic instability; checkpoint and p53 status also influence how cells respond to DNA-damaging therapy. This entry presents these associations as mechanistic background rather than as guidance for diagnosis or treatment of any individual.

History

The checkpoint concept was articulated in yeast genetics as a control that makes later cell-cycle events depend on the completion of earlier ones, and the discovery of damage-responsive checkpoint genes linked it to genome stability. The identification of p53 first as an oncoprotein partner and later as a tumour suppressor, together with the placement of ATM and ATR at the head of the signalling network, brought the checkpoint and p53 strands together into an integrated DNA damage response.

Key figures

• Stephen Elledge
• Michael Kastan
• Karen Vousden
• Carol Prives
• Wei Gu

Seminal works

• zhou-elledge-2000
• bakkenist-kastan-2003
• vousden-prives-2009

Frequently asked questions

What does a cell-cycle checkpoint actually do when DNA is damaged?

It pauses cell-cycle progression at a transition such as G1/S or G2/M, giving the cell time to repair the damage before replication or division proceeds and lesions are propagated.

Why is p53 called the guardian of the genome?

Because damage signalling activates p53 to trigger cell-cycle arrest, senescence, or apoptosis, preventing cells with damaged DNA from dividing; this protective role is why loss of p53 function is so common in cancer.